Anderson Raymond bought MNPR
November 2, 2026 · Form 4 insider transaction
Anderson Raymond bought 1,740 shares of Monopar Therapeutics Inc. at $30.00 per share, a transaction worth $52.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,740
Price
$30.00
Total value
$52.2K
InsiderAnderson Raymond
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after8,515
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On September 18, 2017, the reporting person was granted stock options to purchase up to 4,205 shares of common stock. The options vest 6/42nds at the six-month anniversary of grant date and 1/42nd per month thereafter.